Emerald Mutual Fund Advisers Trust’s BioTelemetry, Inc. BEAT Stock Holding History

Emerald Mutual Fund Advisers Trust’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-1,592	Closed	-$74K	–	340
2019 Q4	$74K	Buy	+1,592	New	+$68.9K	﹤0.01%	242
2018 Q4	–	Sell	-3,337	Closed	-$215K	–	258
2018 Q3	$215K	Buy	+3,337	New	+$186K	0.01%	236

Other funds holding BEAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Emerald Mutual Fund Advisers Trust's BEAT Position: Q1 2020 in Review

Emerald Mutual Fund Advisers Trust sold out of BioTelemetry, Inc. (BEAT) in Q1 2020, closing a stake of 1,592 shares — an estimated $74K sold.

Emerald Mutual Fund Advisers Trust first reported a position in BEAT in Q3 2018 and held it in 2 quarters. The position peaked at $215K in Q3 2018. 209 funds tracked by Wall St. Rank hold BEAT as of Q1 2020.

Emerald Mutual Fund Advisers Trust reported no remaining BioTelemetry, Inc. position as of Q1 2020 after selling out during the quarter.
Emerald Mutual Fund Advisers Trust sold 1,592 BioTelemetry, Inc. shares in Q1 2020, an estimated $74K.
Emerald Mutual Fund Advisers Trust first reported a position in BioTelemetry, Inc. in Q3 2018 and held it in 2 quarters.
Emerald Mutual Fund Advisers Trust's BioTelemetry, Inc. position peaked at $215K in Q3 2018.
209 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2020.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q1 2020, filed 30 Apr 2020.